HealthWarehouse.com Inc. Reports 182% Increase in Q2 Sales and $228,000 Net Income

Reuters
2025/08/13
HealthWarehouse.com Inc. Reports 182% Increase in <a href="https://laohu8.com/S/QTWO">Q2</a> Sales and $228,000 Net Income

HealthWarehouse.com Inc. reported robust financial results for the second quarter of 2025, showcasing a significant 182% increase in net sales, which totaled $15.7 million. This surge was primarily driven by a 495% growth in partner services revenues. The company recorded a net income of $228,000 for the quarter, a notable turnaround from a net loss of $344,000 in the same period the previous year. HealthWarehouse.com also reported an Adjusted EBITDA of $568,000, which marks a substantial improvement compared to the $25,000 reported for the second quarter of 2024. HealthWarehouse.com operates as a technology company focusing on healthcare e-commerce, providing prescription and over-the-counter medications across all 50 states as an Approved Digital Pharmacy through the National Association of Boards of Pharmacy (NABP). The company emphasizes its commitment to enhancing accessibility and reducing costs of healthcare products for consumers and business partners nationwide. No future financial guidance or outlook was provided in the report.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthWarehouse.com Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250812889524) on August 12, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10